[1]
M. A. Mahtab, S. Tabassum, A. Nesa, M. Jahan, M. S. I. Khan, and S. M. F. Akbar, “A new therapeutic option for chronic hepatitis B: Reduced dose and shorter duration of a combination therapy with pegylated interferon and entecavir”, Bangladesh Med Res Counc Bull, vol. 45, no. 3, pp. 143–148, Dec. 2019.